Symyx Direct Bridges the Gap Between Bioinformatics and Cheminformatics

Symyx Direct Bridges the Gap Between Bioinformatics and Cheminformatics 
  
New data cartridge release enables first unified search across complex large biomolecular sequences and small-molecule structures 
 
SUNNYVALE, Calif., June 22, 2010 -Symyx Technologies, Inc. (NASDAQ: SMMX) has released the Symyx Direct 7.0 data cartridge-an innovative, one-stop solution for registering, searching, and retrieving chemical and biological entities stored in relational databases. Supporting the continued expansion of biologics in today's pharmaceutical, biotech, and materials science R&D pipelines, Symyx Direct 7.0 improves R&D efficiency, project team collaboration, and IP management by enabling multidisciplinary project teams to visualize, explore, and compare novel macromolecular sequences and chemical structures stored in a single, fully searchable corporate registry system.
 
 
"Biologics now represent over 30%, and in some cases over 50%, of our customers' product pipelines," said Dr. Trevor Heritage, president, Symyx Software. "Responding to our industry's critical need for end-to-end combined biologics and chemical acquisition, registration, and management-and guided by our Biologics Advisory Board-Symyx is pleased to introduce an enhanced data cartridge that improves the management and re-use of broader, deeper IP in today's increasingly integrated chemical and biological R&D environment."
 
 
Many scientists today are searching for ways to reduce off-target effects and improve the stability of chemically modified short interfering RNA (siRNA) sequences, peptides, and other large molecules. Aiding these efforts, Symyx Direct 7.0 supports natural post- translational modifications (PTM) and custom modifications while also providing seamless support for D-amino acids and complex cyclizations, including the imidazolinone fluorophore found in the fluorescent proteins.
 
 
Symyx Direct 7.0 offers a new, hybrid representation that combines the best features of bioinformatics and cheminformatics notations, improving multidisciplinary collaborative research by enabling scientists to:

Register and retrieve molecules, reactions, and biomolecular sequences including peptides, oligonucleotides, and oligosaccharides
Search for and view chemical modifications in sequences
Develop structure-activity correlations in sequences
Used by more than 80 percent of life sciences organizations worldwide, the Symyx Direct data cartridge offers proven performance with databases containing more than 30 million structures and more than 17 million reactions.
 
 
For more information, contact [email protected]
 
 
About Symyx

Symyx Technologies, Inc. (NASDAQ: SMMX) helps R&D-based companies in life sciences, chemicals, energy, and consumer and industrial products achieve breakthroughs in innovation, productivity, and return on investment. Symyx software and scientific databases power laboratories with the information that generates insight, enhances collaboration, and drives productivity. Products include a market-leading electronic laboratory notebook, decision support software, and chemical informatics and sourcing databases. Information about Symyx, including reports and other information filed by Symyx with the Securities and Exchange Commission, is available at www.symyx.com.

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

A variant of the ACE2 receptor could work as a COVID-19 therapeutic by drawing the virus away from healthy cells, scientists reported.